United States-Israel Alzheimer's Disease Cooperation Act

Summary: United States-Israel Alzheimer's Disease Cooperation Act - Directs the Secretary of Health and Human Services (HHS) to establish a program of grants to support research on the development and commercialization of tools, treatments, and cures for Alzheimer's disease and other dementias. Requires eligible projects to be joint ventures between U.S. and Israeli non-governmental entities or the U.S. and Israeli governments. Establishes an advisory board to monitor the method by which grants are awarded and to provide performance reviews of actions taken to carry out this Act.

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``United States-Israel Alzheimer's 
Disease Cooperation Act''.

SEC. 2. FINDINGS.

    The Congress finds the following:
            (1) It is in the highest national interests of the United 
        States to further research into Alzheimer's disease.
            (2) The State of Israel is a steadfast ally of the United 
        States.
            (3) The special relationship between the United States and 
        Israel is manifested in a variety of cooperative scientific 
        research and development programs, such as--
                    (A) the United States-Israel Binational Science 
                Foundation;
                    (B) the United States-Israel Binational Industrial 
                Research and Development Foundation; and
                    (C) the United States-Israel Energy Cooperation 
                Act.
            (4) Those programs have made possible many scientific, 
        technological, and commercial breakthroughs in fields including 
        the life sciences, medicine, bioengineering, agriculture, 
        biotechnology, communications, and energy development.
            (5) Israeli scientists are at the forefront of research and 
        development in the field of Alzheimer's disease.
            (6) Enhanced cooperation between the United States and 
        Israel for the purpose of research in Alzheimer's disease would 
        be in the national interests of both countries.

SEC. 3. GRANTS FOR ALZHEIMER'S DISEASE RESEARCH.

    (a) Grant Program.--
            (1) Establishment.--The Secretary of Health and Human 
        Services (in this section referred to as the ``Secretary'') 
        shall establish a program of awarding grants to support 
        research on the development and commercialization of applicable 
        tools, treatments, and cures for Alzheimer's disease and other 
        dementias.
            (2) Eligible projects.--To be eligible for funding under 
        this section, a project shall--
                    (A) be designed to further research described in 
                paragraph (1); and
                    (B) be a joint venture between--
                            (i)(I) a for-profit business entity, 
                        academic institution, National Laboratory (as 
                        defined in section 2 of the Energy Policy Act 
                        of 2005 (42 U.S.C. 15801)), or nonprofit entity 
                        in the United States; and
                            (II) a for-profit business entity, academic 
                        institution, or nonprofit entity in Israel; or
                            (ii)(I) the Federal Government; and
                            (II) the Government of Israel.
            (3) Applications.--To seek a grant under this section, an 
        applicant shall submit to the Secretary an application in 
        accordance with procedures established by the Secretary, in 
        consultation with the advisory board established under 
        paragraph (4).
            (4) Advisory board.--
                    (A) Establishment.--The Secretary shall establish 
                an advisory board--
                            (i) to monitor the method by which grants 
                        are awarded under this section; and
                            (ii) to provide to the Secretary periodic 
                        performance reviews of actions taken to carry 
                        out this section.
                    (B) Composition.--The advisory board established 
                under subparagraph (A) shall be composed of 3 members, 
                to be appointed by the Secretary, of whom--
                            (i) 1 shall be a representative of the 
                        Federal Government;
                            (ii) 1 shall be selected from a list of 
                        nominees provided by the United States-Israel 
                        Binational Science Foundation; and
                            (iii) 1 shall be selected from a list of 
                        nominees provided by the United States-Israel 
                        Binational Industrial Research and Development 
                        Foundation.
            (5) Contributed funds.--Notwithstanding section 3302 of 
        title 31, United States Code, the Secretary may accept, retain, 
        and use funds contributed by any person, government entity, or 
        organization for purposes of carrying out this section--
                    (A) without further appropriation; and
                    (B) without fiscal year limitation.
            (6) Report.--Not later than 180 days after the date of 
        completion of a project for which a grant is provided under 
        this section, the grant recipient shall submit to the Secretary 
        a report that contains--
                    (A) a description of the method by which the 
                recipient used the grant funds; and
                    (B) an evaluation of the level of success of each 
                project funded by the grant.
            (7) Classification.--Grants shall be awarded under this 
        section only for projects that are considered to be 
        unclassified by both the United States and Israel.
    (b) Termination.--The grant program and the advisory committee 
established under this section terminate on the date that is 7 years 
after the date of enactment of this Act.
    (c) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this section $3,000,000 for the period of 
fiscal years 2015 through 2021. Any amounts appropriated pursuant to 
this subsection shall be in addition to amounts accepted, retained, and 
used pursuant to subsection (a)(5).